PIC/S Guideline Sets Harmonized Approach For Classifying GMP Deficiencies Worldwide
Executive Summary
PIC/S has issued guidance to help member pharmaceutical inspectorates classify good manufacturing practice deficiencies to ensure there is a consistent view across inspectorates as to which deficiencies are “critical” or “major.”
You may also be interested in...
PIC/S To Guide Member Inspectorates On Harmonizing GMP Deficiency Classifications
Draft guidance soon will help the world’s leading pharmaceutical inspectorates align views on which drug GMP deficiencies are considered major – and which are truly critical.
PIC/S explores harmonized approach to classifying GMP deficiencies
The Pharmaceutical Inspection Convention and Co-operation Scheme is looking at possible approaches to harmonizing the classification of good manufacturing practice deficiencies and identify the most common GMP deficiencies noted during inspections1.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”